Clinical Trials

Clinical Trials for MTG8

Filter list of Clinical Trials

TopicTrial name of investigational drugClinical Trial ID(s)StatusOrphaCodeLink
Graves’ hyperthyroidismSelenium supplementation for patients with Graves’ hyperthyroidism (the GRASS trial)
  • NCT01611896
  • concluded
Medullary Thyroid CarcinomaA Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer (EXAMINER)
  • NCT01896479
  • completed
  • ORPHA1332
Medullary Thyroid CarcinomaA Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
  • NCT04211337
  • EUDRACT: 2019-001978-28
  • ongoing
  • recruiting
  • ORPHA1332
Thyroid CarcinomaPhase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (ARROW)
  • NCT03037385
  • ongoing
  • ORPHA1332
Anaplastic Thyroid CarcinomaNEO adjuvant Treatment in Anaplastic Cancer of the Thyroid (NEO-TACT study) (in preparation) Clinical Study: Focus on values to stimulate shared decisions in patients with thyroid cancer: A multifaceted COMmunication Booster (COMBO).
  • NCT01099436
  • recruiting
  • ORPHA142
Thyroid CarcinomaLenvatinib
  • 2014-005199-27
  • Results
  • ORPHA146
Thyroid CarcinomaFocus on Values to Stimulate Shared Decisions in Patients With Thyroid Cancer: A Multifaceted COMmunication BOoster (COMBO)s
  • NCT03905369
  • ongoing
  • ORPHA146
Thyroid NeoplasmsFDG-PET/CT in Evaluation of Cytological Indeterminate Thyroid Nodules to Prevent Unnecessary Surgery (EfFECTS) (EfFECTS)
  • NCT02208544
  • completed
  • ORPHA146
Transition,paediatric chronic endocrine disordersGrowing up With the Young Endocrine Support System (YESS!) (YESS)
  • NCT04252001
  • ongoing
  • ORPHA418
  • ORPHA174590
  • ORPHA881
  • ORPHA95488
  • ORPHA85138
  • ORPHA754
  • ORPHA9571
  • ORPHA95494
McCune- Albright SyndromeMCRN007 (D6992C00044) - An Open-Label, Non-Comparative Trial To Evaluate The Safety, Efficacy And Pharmacokinetics Of FASLODEX™ (Fulvestrant) In Girls With Progressive Precocious Puberty Associated With Mccune Albright Syndrome
  • NCT00278915
  • ongoing
  • ORPHA562
MCT8 DeficiencyThyroid Hormone Analog Therapy in MCT8 Deficiency: Triac Trial Patients
  • NCT02060474
  • completed
  • ORPHA59
MCT8 DeficiencyTriac Trial II in MCT8 Deficiency Patients
  • NCT02396459
  • ongoing
  • recruiting
  • ORPHA59
Medullary Thyroid CancerLibretto-531 study
  • 2019-001978-28
  • J2G-MC-JZJB
  • ongoing
  • ORPHA1332
TopicTrial name of investigational drugClinical Trial ID(s)StatusOrphaCodeLink

An overview of all Clinical Trials can be found here.